Amazon to acquire One Medical for €3.8bn

The acquisition represents Amazon's most recent effort to establish itself as a major force in the healthcare sector, following its recent forays into telehealth services and online pharmacies.

The company will pay One Medical shareholders $18 per share, a more than 75 per cent premium on its closing price on Wednesday. The San Francisco company’s stock price closed up 69 percent on Thursday.

The acquisition is the latest attempt by Amazon to become a leading player in the healthcare industry, from becoming an online pharmacy to providing telehealth services. One Medical offers a subscription-based model where users can pay a monthly fee to have access to doctors.

"We believe healthcare is high on the list of experiences that require innovation," said Neil Lindsay, senior vice president of Amazon Health Services.

One Medical went public in early 2020, and its share price jumped during the coronavirus epidemic, but company has failed to maintain the pace, with shares presently trading below their IPO price. Its main owners are hedge fund Tiger Global and private equity firm Carlyle.

The debt-financed transaction is expected to serve as a litmus test for US antitrust officials under the Biden administration, who have been openly skeptical of Big Tech's monopolistic position.

Lina Khan, chairperson of the Federal Trade Commission, and Jonathan Kanter, head of antitrust at the US Department of Justice, have both stated that it is critical to limit the market dominance wielded by giant digital corporations like Amazon and Google.

In 2020, Amazon created an online pharmacy that provided prescription medications at a reduced cost. It had paid almost $1 billion for PillPack, a mail-order pharmacy that prepares and mails pills.

Stocks of publicly traded pharmacies had decreased dramatically as a result of Amazon's entry into the industry at the time of the PillPack purchase.

In this area, the corporation is also utilizing its Amazon Web Capabilities cloud and AI services so that data may be utilized to improve health.

Amazon faces competition from Alphabet, which purchased fitness monitoring startup Fitbit last year, and DeepMind, a London-based AI company that acquired Google Health in 2014. 

Tags : #AMAZON #ONEMEDICAL #FEATURED #GOOGLEHEALTH #FITBIT #DEEPMIND #teleheath #medicircle #smitakumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024